Nitrofurantoin is not dangerous for most people when used as a short course for urinary tract infections. It has been prescribed since the 1950s, and for a typical 3-to-7-day treatment, serious side effects are rare. The real risks emerge with long-term use, reduced kidney function, certain genetic conditions, and use late in pregnancy. Understanding these specific situations is the key to knowing whether this drug poses a concern for you.
Why It’s Generally Well Tolerated
Nitrofurantoin works differently from most antibiotics. Once inside bacteria, enzymes convert it into reactive compounds that attack multiple targets at once, disrupting DNA, RNA, and protein production simultaneously. Because this activation depends on enzymes found specifically in bacteria, human cells are largely spared. This multi-target approach also explains why bacteria have been slow to develop resistance to it, even after decades of use.
In a large study tracking patients prescribed nitrofurantoin, 89% had no drug-related adverse event at all. About 5% experienced minor complaints like nausea, diarrhea, or headache. Allergic reactions occurred in roughly 2% of cases. Serious organ-level side effects (lung or liver injury) were identified in about 4% of flagged cases, though the actual rate across all users is much lower, as these flagged cases were already suspected problems.
Common Side Effects
The most frequent complaints are gastrointestinal: nausea, diarrhea, and stomach discomfort. Taking the medication with food reduces these symptoms significantly. Headaches also occur occasionally. These side effects are generally mild and resolve once you finish the course. For a standard short treatment, this is typically all you’ll experience.
Lung Injury: Acute and Chronic Forms
The most discussed serious risk with nitrofurantoin is lung toxicity, which comes in two distinct forms.
The acute form can develop within hours to weeks of starting the drug. It causes fever, cough, and shortness of breath, and is essentially an immune overreaction. This happens in roughly 1 in 5,000 patients after initial exposure. The good news: symptoms typically improve within 24 to 72 hours of stopping the medication.
The chronic form is rarer (10 to 20 times less common than the acute form) but more concerning. It develops after six or more months of continuous use and causes a gradual worsening of cough and breathlessness, usually without fever. Over time, it can lead to scarring in the lungs. About 1 in 750 long-term users develops respiratory problems severe enough to need hospitalization. Recovery after stopping the drug takes weeks to months, and in some cases, lung damage is not fully reversible.
This is why lung toxicity is primarily a concern for people on long-term preventive courses rather than a standard short treatment.
Liver Injury
Nitrofurantoin can cause liver damage in two patterns. The acute form is very rare, occurring in roughly 0.3 cases per 100,000 prescriptions, and typically shows up within the first week as fever, rash, and yellowing of the skin.
The chronic form is more common, estimated at roughly 1 in 1,500 to 1 in 5,000 people who take the drug long-term. It mimics autoimmune hepatitis, where the immune system attacks liver tissue. In a review of 42 cases of nitrofurantoin-related liver injury, all were women with a median age of 65. Autoimmune features were present in 83% of cases. About 30% had a severe course, and a small number required liver transplant or died.
The encouraging part: unlike true autoimmune hepatitis, this condition generally resolves once the medication is stopped. But it underscores why anyone on long-term nitrofurantoin should have liver function checked regularly.
Nerve Damage
Peripheral neuropathy, a condition causing numbness, tingling, or pain in the hands and feet, is a rare but real side effect. It is most associated with prolonged use and tends to be underrecognized. In one documented case, a patient who took nitrofurantoin intermittently and then continuously over seven years developed severe sensory neuropathy. She recovered almost completely after stopping the drug. The risk increases with impaired kidney function, because the drug accumulates to higher levels when the kidneys can’t clear it efficiently.
Kidney Function Matters
Your kidneys play a double role with nitrofurantoin: they eliminate the drug from your body and concentrate it in the urine, which is where it needs to be to fight a UTI. When kidney function drops too low, two problems arise simultaneously. The drug builds up in your bloodstream (increasing the risk of side effects), and not enough reaches the urine (making it less effective against the infection).
Current guidelines set the cutoff at an eGFR below 45 ml/min. Below that level, nitrofurantoin should not be used in most cases. A short course of 3 to 7 days may still be considered with caution if your eGFR falls between 30 and 44, but below 30 it is generally avoided entirely. This threshold was previously more restrictive (set at 60 ml/min), so older adults who were once told they couldn’t take it may now be eligible for short courses.
G6PD Deficiency and Hemolytic Anemia
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency face a specific danger. G6PD is an enzyme that protects red blood cells from oxidative damage. Nitrofurantoin generates reactive compounds that stress red blood cells, and without enough G6PD activity, those cells break apart. This is called hemolytic anemia, and it can be severe.
G6PD deficiency affects an estimated 400 million people worldwide, predominantly men of African, Mediterranean, Middle Eastern, and Southeast Asian descent. If you have this condition or don’t know your G6PD status and belong to a higher-risk group, this is worth raising with your prescriber.
Risks in Pregnancy
Nitrofurantoin is commonly prescribed for UTIs during pregnancy and is considered probably safe by the FDA (Category B). However, it is contraindicated near the end of pregnancy, specifically from about 38 weeks onward and during labor. The reason: newborns have immature enzyme systems in their red blood cells, making them vulnerable to the same kind of hemolytic anemia seen in G6PD deficiency. Exposure close to delivery can trigger a hemolytic crisis in the newborn. Earlier in pregnancy, the risk-benefit balance generally favors treatment, since untreated UTIs carry their own serious risks.
Long-Term Use Requires Monitoring
The pattern across all of nitrofurantoin’s serious side effects is clear: short courses are low risk, while long-term suppressive therapy (used to prevent recurrent UTIs) carries meaningfully higher danger. If you’re taking nitrofurantoin daily for months, current guidelines recommend baseline and regular follow-up monitoring every three to six months. This should include liver function tests, checks for breathing symptoms, and oxygen level measurements.
UK prescribing authorities recommend reconsidering the prescription beyond six months of continuous use, weighing ongoing benefits against the cumulative risk of lung and liver injury. If you develop a new cough, increasing shortness of breath, unexplained fatigue, or yellowing of the skin while on long-term nitrofurantoin, stopping the drug promptly is important, as early detection leads to better recovery outcomes.